Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Niklas Muenchmeier"'
Autor:
Niklas Muenchmeier, Sophia Boecker, Lorenz Bankel, Laura Hinz, Nicole Rieth, Constantin Lapa, Anna N Mendler, Elfriede Noessner, Ralph Mocikat, Peter J Nelson
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e72749 (2013)
BACKGROUND: Cellular therapy is a promising therapeutic strategy for malignant diseases. The efficacy of this therapy can be limited by poor infiltration of the tumor by immune effector cells. In particular, NK cell infiltration is often reduced rela
Externí odkaz:
https://doaj.org/article/a767ad6f616b48279f2d0cdeb9ac8030
Autor:
Christoph Tinchon, Shanow Uthman, Thamer Sliwa, Wolfgang R. Sperr, Clemens Dormann, Stefan Schmidt, Peter Valent, Sonja Burgstaller, Veronika Buxhofer-Ausch, Richard Greil, Andreas L. Petzer, Niklas Muenchmeier, Alois Lang, Albert Wölfler, Petra Pichler, Florian Goebel
Publikováno v:
Wiener Klinische Wochenschrift
Summary Background Several clinical trials in chronic phase (CP) chronic myeloid leukemia (CML) showed that early response to tyrosine kinase inhibitor (TKI) treatment results in an improved long-term survival and progression-free survival. This stud
Autor:
Christian Kupatt, Peter J. Nelson, Franziska Götz, Chiraz El Aouni, Achim Pfosser, Georg Stachel, Teresa Trenkwalder, Markus Sperandio, Antonis K. Hatzopoulos, Rabea Hinkel, Niklas Muenchmeier, Claudia Nussbaum
Publikováno v:
Stem Cells. 31:1795-1805
The facilitated recruitment of vascular progenitor cells (VPCs) to ischemic areas might be a therapeutic target for neovascularization and repair. However, efficient and directed attraction of VPCs remains a major challenge in clinical application. T
Autor:
Monika Hofstetter, Roghieh Djafarzadeh, Peter J. Nelson, Birgit Jahn, Matthias C. Raggi, Niklas Muenchmeier, Nicole Rieth
Publikováno v:
bchm. 390:893-897
Exogenous application of recombinant TIMP-1 protein modified by addition of a glycosylphosphatidylinositol (GPI) anchor allows efficient insertion of the fusion protein into cell membranes. This ‘cell surface engineering’ leads to changes in the
Autor:
Laura Hinz, Niklas Muenchmeier, Nicole Rieth, Sophia Boecker, Peter J. Nelson, Elfriede Noessner, Anna N. Mendler, Lorenz Bankel, Constantin Lapa, Ralph Mocikat
Publikováno v:
PLoS ONE 8:e72749 (2013)
PLoS ONE, Vol 8, Iss 8, p e72749 (2013)
PLoS ONE
PLoS ONE, Vol 8, Iss 8, p e72749 (2013)
PLoS ONE
Background Cellular therapy is a promising therapeutic strategy for malignant diseases. The efficacy of this therapy can be limited by poor infiltration of the tumor by immune effector cells. In particular, NK cell infiltration is often reduced relat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf2a98d899d7984ad7ae33146498458
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=27373
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=27373
Autor:
Niklas Muenchmeier, Nicole Rieth, Petra U. Prinz, David Anz, Ainhoa-M. Figel, Peter J. Nelson, Alexander Buchner, Stefan Porubsky, Judith Eckl, Ulrike K. Lettenmeyer, Adriana Turqueti-Neves, Elfriede Noessner, Stephan Segerer, Josef Mysliwietz, Sabine Siegert, Dorothee Brech
Publikováno v:
AMERICAN JOURNAL OF PATHOLOGY
Am. J. Pathol. 179, 436-451 (2011)
Am. J. Pathol. 179, 436-451 (2011)
Tissue dendritic cells (DCs) may influence the progression of renal cell carcinoma (RCC) by regulating the functional capacity of antitumor effector cells. DCs and their interaction with T cells were analyzed in human RCC and control kidney tissues.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9f42f629dbf5bca058d2bb30a417063
https://doi.org/10.5167/uzh-53895
https://doi.org/10.5167/uzh-53895
Autor:
Andreas J. Kungl, Niklas Muenchmeier, Norbert Gretz, Eva Kiss, Carl Ludwig Behnes, Angelika Rek, Hermann Josef Gröne, Peter J. Nelson, Jens Bedke
Publikováno v:
Molecular immunology. 47(5)
Acute renal allograft damage is caused by early leukocyte infiltration which is mediated in part by chemokines presented by glycosaminoglycan (GAG) structures on endothelial surfaces. CXCL8 can recruit neutrophils and induce the firm arrest of monocy